Shah AT, Blanchard I, Padda SK, Wakelee HA, et al. Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer. Clin Lung Cancer 2024 Jun 19:S1525-7304(24)00133.
PMID: 38987048